BCG vaccine for clinically isolated syndrome and MS
BCG vaccine for clinically isolated syndrome and MS
D. Bourdette,R. Naismith
2014 · DOI: 10.1212/01.wnl.0000438232.40847.c3
Neurology · 54 Citations
TLDR
It follows that better sanitation and common use of disinfectants and antibiotics may account in part for the increased prevalence of MS and other autoimmune diseases in North America and much of Europe, compared with Africa, South America, and parts of Asia.
